CoChat
Sign Up
Cited by 251Monoclonal and Polyclonal Antibodies ResearchHistorical Medical Research and TreatmentsBacterial Infections and Vaccines

Serum therapy revisited: animal models of infection and development of passive antibody therapy

Open access
Casadevall, A, Scharff, M D·1994·Antimicrobial Agents and Chemotherapy
DOI 10.1128/aac.38.8.1695PMC PMC284624
Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1128/aac.38.8.1695

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Clinical benefit of passive immunization was demonstrated for invasive bacterial infections, various viral diseases, and anti-fungal therapy.

    “Clinical benefit was demonstrated for invasive bacterial infections (Casadevall & Scharff, 1994), for various viral diseases (Janeway, 1945; Hammon et al, 1953), as well as for anti‐fungal therapy (Bugli et al, 2013)”

    From mRNA mediates passive vaccination against infectious agents, toxins, and tumors (2017) · cites this paper as Casadevall & Scharff, 1994

Cites

Flagged first, then by citations

1 of the 84 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Related

Authors
Casadevall, A., & Scharff, M. D.
Affiliations
Albert Einstein College of Medicine (US)
ORCID
Venue
Antimicrobial Agents and Chemotherapy
Publisher
American Society for Microbiology
Published
1994-08
Volume
38
Issue
8
Pages
1695-1702
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
DOI
10.1128/aac.38.8.1695
PMC
PMC284624
OpenAlex
W2031152984
Cited by
251
References
84
Citations by year
2025: 8 · 2024: 6 · 2023: 10 · 2022: 10 · 2021: 20 · 2020: 29 · 2019: 5 · 2018: 7 · 2017: 10 · 2016: 4 · 2015: 6 · 2014: 12 · 2013: 6 · 2012: 8
FWCI
5.86
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Antimicrobial Agents and Chemotherapy (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Cancer Institute (CA-39839)
  • National Institute of Allergy and Infectious Diseases (AI13342, AI33774, R01AI033774)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Historical Medical Research and Treatments
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords
serum therapy, animal models of infection, passive antibody therapy, passive immunization
MeSH terms
Animals, Disease Models, Animal, Humans, Immunization, Passive, Meningitis, Meningococcal, Pneumococcal Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review